|
CN105218434A
|
|
Carbinoxamine maleate crystal formation and preparation method thereof
|
|
CN104856976A
|
|
Fenofibrate sustained release capsule and preparation method thereof
|
|
CN104761453A
|
|
Dimethyl fumarate crystal form and preparation method thereof
|
|
CN104761458A
|
|
S-metoprolol succinate crystal form and preparation method thereof
|
|
CN104744342A
|
|
Dexmethylphenidate hydrochloride crystal form and preparation method thereof
|
|
CN104628564A
|
|
Fenofibric acid choline salt crystal form and preparation method thereof
|
|
CN104529941A
|
|
Preparation method of non-chlorine gas of acetazolamide key intermediate 2-acetamido-5-chlorosulfonyl-1, 3, 4-thiadiazole
|
|
CN104530005A
|
|
Method for preparing high-purity (R)-lansoprazole
|
|
CN104490801A
|
|
Crushable tablet for infants and children and preparation method thereof
|
|
CN104434848A
|
|
Oral solid preparation released at given time and preparation method thereof
|
|
CN104382882A
|
|
PH-independent zaleplon dipulse release capsule and method for preparing same
|
|
CN103690545A
|
|
Oral prednisone time-selecting release preparation and preparation method thereof
|
|
CN103450128A
|
|
Preparation method of prostaglandin analogue midbody Corey aldehyde for treating glaucoma
|
|
CN103340835A
|
|
Orally disintegrating tablet suitable for infants and children and preparation method thereof
|
|
CN102952128A
|
|
Refining method of vinpocetine
|
